Moreover, interleukin 10 signaling, signaling by interleukin, interleukin 4, and interleukin 13 signaling are also enriched in MES, suggesting a significant association with immune and inflammation responses in MES patients. The gene discussed is IL4; the disease is Meckel syndrome, type 1.